Skip to main content

Table 1 Patient characteristics

From: Plasma mRNA expression levels of BRCA1 and TS as potential predictive biomarkers for chemotherapy in gastric cancer

Characteristic

Pilot study

Total cohort*

N = 40

N = 150

N (%)

N (%)

Age, yr, median (range)

63 (40-83)

64 (29-84)

Sex

  

  Male

31 (77.5)

110 (73.3)

  Female

9 (22.5)

40 (26.7)

Tumor site

  

  Distal stomach

12 (30.0)

57 (34.0)

  Proximal stomach

19 (47.5)

62 (41.3)

  Whole stomach

9 (22.5)

37 (24.7)

Stage

  

  I

4 (10.0)

17 (11.3)

  II

9 (22.5)

34 (22.7)

  III

25 (62.5)

94 (62.7)

  IV

2 (5.0)

5 (3.3)

Histological grade

  

  1

0

3 (2.0)

  2

8 (20.0)

31 (20.7)

  3

22 (55.0)

71 (47.3)

  Mixed 1–2

0

2 (1.3)

  Mixed 2–3

10 (25.0)

43 (28.7)

Lymph node metastasis

  

  No

9 (22.5)

35 (23.3)

  Yes

31 (77.5)

115 (76.7)

  1. *The total cohort consisted of the original 40 patients included in the pilot study plus an additional 110 patients.